Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs)

Journal of Colloid and Interface Science

Volumn 363, Issue 1, 2011, Pages 403-409

  Chang, Yulei ^a   Meng, Xinlei ^a   Zhao, Yili ^a   Li, Kun ^a   Zhao, Bao ^a   Zhu, Ming ^a   Li, Yapeng ^a   Chen, Xuesi ^b   Wang, Jingyuan ^a  

^a JILIN UNIVERSITY   (China)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

Dendrimers; DOX; Doxorubicin; Iron oxide NPs; PAMAM

Indexed keywords

ANTICANCER DRUG; CANCER DIAGNOSIS; CANCER THERAPY; DOX; DOXORUBICIN; DRUG RELEASE; DRUG RELEASE SYSTEM; ENHANCED PERMEABILITY AND RETENTION EFFECTS; HYDRAZONE BONDS; IN-VIVO; NANOCARRIERS; PAMAM; PAMAM DENDRIMER; PH-RESPONSIVE; RELEASE PROFILES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDES; TARGET SITES;

DENDRIMERS; DISEASES; DRUG THERAPY; IRON; MOTION PICTURE EXPERTS GROUP STANDARDS; NANOPARTICLES; PH EFFECTS; SUPERPARAMAGNETISM;

IRON OXIDES;

DENDRIMER; DOXORUBICIN; HYDRAZINE; HYDRAZONE DERIVATIVE; HYDROLASE; IODINATED CONTRAST MEDIUM; MACROGOL 400; NANOCARRIER; NANOCONJUGATE; POLYAMIDOAMINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CONTRAST RADIOGRAPHY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RETENTION; FEMALE; ION PERMEABILITY; LYSOSOME; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TARGET CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; DENDRIMERS; DOXORUBICIN; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICE; MOLECULAR STRUCTURE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; WATER;

EID: 80052096110     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2011.06.086     Document Type: Article

References (33)

1. Laginha K.M., Verwoert S., Charrois G.J.R., Allen T.M. Clin. Cancer Res. 2005, 11:6944-6949.
2. Aryal S., Grailer J.J., Steeberband S.P.D.A., Gong S. J. Mater. Chem. 2009, 19:7879-7884.
3. Frederick C.A., Williams L.D., Ughetto G., van der Marel G.A., van Boom J.H., Rich A., Wang A.H.J. Biochemistry 1990, 29:2538-2549.
4. Etrych T., Jelinkova M., Rihova B., Ulbrich K. J. Controlled Release 2001, 73:89-102.
5. Lee Y., Park S.Y., Mok H., Park T.G. Bioconjugate Chem. 2008, 19:525-531.
6. Marchi N., Hallene K.L., Kight K.M., Cucullo L., Moddel G., Bingaman W., Dini G., Vezzani A., Janigro D. BMC Med. 2004, 2:1-10.
7. Batrakova E.V., Kelly D.L., Li S., Li Y., Yang Z., Xiao L., Alakhova D.Y., Sherman S., Alakhov V.Y., Kabanov A.V. Mol. Pharm. 2006, 3:113-123.
8. Marin A., Sun H., Husseini G.A., Pitt W.G., Christensen D.A., Rapoport N.Y. J. Controlled Release 2002, 84:39-47.
9. Eichman J., Bielinska A., Kukowska-Latallo J., Donovan B., Baker J. 2001, 441-462. Wiley, Chisester. J. Frechet, D. Tomalia (Eds.).
10. Khuloud, Al-Jamal, Sakthivel T., Florence A. Int. J. Pharm. 2003, 254:33-36.
11. Papagiannaros A., Dimas K., Papaioannou G.T., Demetzos C. Int. J. Pharm. 2005, 302:29-38.
12. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., Zink J.I. ACS Nano. 2008, 2:889-896.
13. Chen W., Xu N., Xu L., Wang L., Li Z., Ma W., Zhu Y., Xu C., Kotov N.A. Macromol. Rapid Commun. 2010, 31:228-236.
14. Son S., Reichel J., He B., Schuchman M., Lee J. Am. Chem. Soc. 2005, 127:7316-7317.
15. Seo W.S., Lee J.H., Sun X., Suzuki Y., Mann D., Liu Z., Terashima M., Yang P.C., Mcconnell M.V., Nishimura D.G., Dai H.J. Nat. Mater. 2006, 5:71-976.
16. Zhao W., Gu J., Zhang L., Chen H., Shi J. J. Am. Chem. Soc. 2005, 127:8916-8917.
17. Li W., Szoka F.C. Pharm. Res. 2007, 24:438-449.
18. Lee H., Lee E., Kim D.K., Jang N.K., Jeong Y.Y., Jon S. J. Am. Chem. Soc. 2006, 128:7383-7389.
19. Yang J., Lee T., Lee J., Lim E.K., Hyung W., Lee C.H., Song Y.J., Suh J.S., Yoon H.G., Huh Y.M., Haam S. Chem. Mater. 2007, 19:3870-3876.
20. Zhao Y., Liu S., Li Y., Jiang W., Chang Y., Pan S., Fang X., Andrew Wang Y., Wang J. J. Colloid. Interface. Sci. 2010, 350:44-50.
21. Chytil P., Etrych T., Koňák Č., Šírová M., Mrkvan T., Bouček J., Říhová B., Ulbrich K. J. Controlled Release 2008, 127:121-130.
22. Chytil P., Etrych T., Koňák Č., Šírová M., Mrkvan T., Říhová B., Ulbrich K. J. Controlled Release 2006, 115:26-36.
23. Xu Z., Shen C., Hou Y., Gao H., Sun S. Chem. Mater. 2009, 21:1778-1780.
24. Zhao Y., Li Y., Song Y., Jiang W., Wu Z., Andrew Wang Y., Sun J., Wang J. J. Colloid. Interface. Sci. 2009, 339:336-343.
25. Zhu S., Hong M., Zhang L., Tang G., Jiang Y., Pei Y. Pharm. Res. 2010, 27:161-174.
26. Ke W., Zhao Y., Huang R., Jiang C., Pei Y. J. Pharm. Sci. 2008, 97:2208-2216.
27. Lee Y., Park S.Y., Mok H., Park T.G. Bioconjugate Chem. 2008, 19:525-531.
28. Chandra S., Mehta S., Nigam S., Bahadur D. New J. Chem. 2010, 34:648-655.
29. Park J., Yu M.K., Jeong Y.Y., Kim J.W., Lee K.L., Phan V.N., Jon S. J. Mater. Chem. 2009, 19:6412-6417.
30. Moghimi S.M., Hunter A.C., Murray J.C. Pharmacol. Rev. 2001, 53:283-318.
31. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. Nature Biotechnol. 2004, 22:1-10.
32. Wang J., Sui M., Fan W. Curr. Drug Metab. 2010, 11:129-141.
33. Wang M., Thanou M. Pharmacol. Res. 2010, 62:90-99.